Hormone replacement therapy and endometrial cancer: Are current regimens safe?

Journal of the National Cancer Institute

Volumn 89, Issue 15, 1997, Pages 1088-1089

  Grady, D ^a   Ernster, V L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE;

CANCER RISK; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; DRUG FORMULATION; DRUG MIXTURE; DRUG SAFETY; DYSPHORIA; EDITORIAL; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; FEMALE; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE;

EID: 0030833698     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/89.15.1088     Document Type: Editorial

References (12)